TY  - GEN
AU  - Torres, Montserrat
AU  - Corona, Magdalena
AU  - Rodríguez-Mora, Sara
AU  - Casado-Fernández, Guiomar
AU  - Zurdo-Castronuño, Alejandro
AU  - Mateos, Elena
AU  - Ramos-Martín, Fernando
AU  - Sánchez-Menéndez, Clara
AU  - Murciano-Antón, María Aranzazu
AU  - García-Pérez, Javier
AU  - Alcamí, José
AU  - Perez-Olmeda, Mayte
AU  - Coiras, Mayte
AU  - López-Jiménez, Javier
AU  - García-Gutiérrez, Valentín
AU  - The Multidisciplinary Group Of Study Of Covid-Mgs-Covid
PY  - 2022
DO  - 10.3390/cancers14225537
SN  - 2072-6694
UR  - http://hdl.handle.net/20.500.12105/15431
AB  - The humoral immune response developed after receiving the full vaccination schedule against COVID-19 is impaired in individuals who received anti-CD20 therapy 6-9 months before vaccination. However, there is little information about the cellular...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - COVID-19 vaccine
KW  - Anti-CD20
KW  - Rituximab
KW  - Hematological malignancies
KW  - Cytotoxic response
KW  - Humoral response
TI  - Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
TY  - research article
ER  -